首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of biomedical informatics

缩写:J BIOMED INFORM

ISSN:1532-0464

e-ISSN:1532-0480

IF/分区:4.5/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引3247
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Tien-Yu Chang,Qinglin Gou,Leyi Zhao et al. Tien-Yu Chang et al.
Objective: Lung cancer is the most prevalent cancer and the leading cause of cancer-related death in the United States. Lung cancer screening with low-dose computed tomography (LDCT) helps identify lung cancer at an early...
Yanlei Kang,Haoyu Zhuang,Yunliang Jiang et al. Yanlei Kang et al.
The prediction of drug-target interactions (DTIs) and binding affinities (DTAs) plays a pivotal role in drug discovery and design. However, most existing methods fail to fully exploit the rich multimodal information inherent in molecular st...
Qiuyang Feng,Xiao Huang Qiuyang Feng
Drug-drug interactions are a major concern in healthcare, as concurrent drug use can cause severe adverse effects. Existing machine learning methods often neglect data imbalance and DDI directionality, limiting clinical reliability. To over...
Luke Stevens,Nan Kennedy,Rob J Taylor et al. Luke Stevens et al.
Objective: Since 2012, the electronic data capture platform REDCap has included an embedded randomization module allowing a single randomization per study record with the ability to stratify by variables such as study sit...
Şeyma Selcan Mağara,Noah Dietrich,Ali Burak Ünal et al. Şeyma Selcan Mağara et al.
Objective: Record linkage is essential for integrating data from multiple sources with diverse applications in real-world healthcare and research. Probabilistic Privacy-Preserving Record Linkage (PPRL) enables this integr...
Biyang Zeng,Shikui Tu,Lei Xu Biyang Zeng
Predicting the synergy of drug combinations is crucial for cancer treatment and drug development. Accurate prediction requires the integration of multiple types of data, including molecular structures of individual drugs, available synergy ...
Radovan Tomasik,Simon Konar,Niina Eklund et al. Radovan Tomasik et al.
Objective: Biobanks and biomolecular resources are increasingly central to data-driven biomedical research, encompassing not only metadata but also granular, sample-related data from diverse sources such as healthcare sys...
Christina A van Hal,Elmer V Bernstam,Todd R Johnson Christina A van Hal
Objective: Randomized Controlled Trials (RCTs) are the gold standard for clinical evidence, but ethical and practical constraints sometimes necessitate or warrant the use of observational data. The aim of this study is to...
Mingxuan Li,Shuai Li,Zhen Li et al. Mingxuan Li et al.
Drug Repositioning (DR) represents an innovative drug development strategy that significantly reduces both cost and time by identifying new therapeutic indications for approved drugs. Current methods primarily focus on extracting informatio...